Asymchem Laboratories (Tianjin) Co., Ltd.
002821
Classifica tra le azioni
#2511
Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development... Asymchem Laboratories (Tianjin) Co., Ltd. functions as a contract development and manufacturing organization (CDMO), offering its expertise to pharmaceutical and biotechnology companies both globally and within Mainland China. Their services encompass drug research, development, and production, supporting projects across the entire drug lifecycle, from early clinical phases to commercial scale. This includes R&D and cGMP-compliant manufacturing of advanced intermediates, active pharmaceutical ingredients (APIs), and finished drug formulations, in addition to providing clinical research support. Furthermore, Asymchem engages in pharmaceutical analysis and testing, the distribution (wholesale, retail, and direct sale) of medicines, and initiatives focused on advancing pharmaceutical science and technology. The company, established in 1999, maintains its headquarters in Tianjin, China.
Prezzo delle azioni
$20.91
Capitalizzazione di mercato
$7.57B
Variazione (1 giorno)
-8.26%
Variazione (1 anno)
41.25%
Paese
CN
Scambia Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Categoria
Healthcare
Ricavi di Asymchem Laboratories (Tianjin) Co., Ltd. (002821)
Ricavi nel Jun 2026 TTM: $1.06B
Secondo gli ultimi rapporti finanziari di Asymchem Laboratories (Tianjin) Co., Ltd., i ricavi attuali dell'azienda (TTM) sono pari a $1.06B. Nel 2024, l'azienda ha registrato ricavi di $795.26M una diminuzione rispetto a i ricavi dell'anno 2023, che erano pari a $1.11B. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Asymchem Laboratories (Tianjin) Co., Ltd. da 2011 a 2026
Ricavi alla fine di ogni anno
| Anno | Ricavi | Cambia |
|---|---|---|
| 2026 (TTM) | $1.06B | 11.34% |
| 2025 | $953.37M | 19.88% |
| 2024 | $795.26M | -28.06% |
| 2023 | $1.11B | -25.46% |
| 2022 | $1.48B | 103.50% |
| 2021 | $728.79M | 51.78% |
| 2020 | $480.16M | 35.91% |
| 2019 | $353.28M | 32.44% |
| 2018 | $266.75M | 21.96% |
| 2017 | $218.72M | 37.65% |
| 2016 | $158.90M | 24.23% |
| 2015 | $127.91M | 10.62% |
| 2014 | $115.63M | 29.23% |
| 2013 | $89.48M | 31.47% |
| 2012 | $68.06M | 5.76% |
| 2011 | $64.35M | 0.00% |
Ricavi di aziende simili o concorrenti
| Azienda | Ricavi | Differenza nei ricavi | Il paese |
|---|---|---|---|
| $12.62B | 1,089.29% |
US
|
|
| $2.23B | 109.89% |
US
|
|
| $15.74B | 1,383.22% |
AU
|
|
| $10.11B | 852.50% |
BE
|
|
| $6.02B | 467.25% |
NL
|
